NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 30,850
-1,600 (-4.93%)
At close: Feb 6, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 350.61 billion as of February 6, 2026. Its market cap has increased by 90.23% in one year.
Market Cap
350.61B
Enterprise Value
334.14B
Revenue
32.96B
Ranking
n/a
PE Ratio
112.60
Stock Price
30,850.00
Market Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 350.61B, an increase of 836.61%. That is a compound annual growth rate of 16.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 350.61B | -17.82% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ToolGen | 508.74B |
| S.Biomedics | 400.04B |
| GC Cell | 381.69B |
| Y-Biologics | 346.06B |
| ABION | 306.79B |
| Genome & Company | 292.36B |
| curacle co.,ltd. | 260.93B |
| Vaxcell-Bio Therapeutics | 229.78B |